<DOC>
	<DOCNO>NCT01568216</DOCNO>
	<brief_summary>The purpose study evaluate effect AMG 747 negative symptom schizophrenia patient stable current antipsychotic treatment . After run-in period current antipsychotic treatment , patient randomize one four treatment arm add-on therapy treatment duration 3 month .</brief_summary>
	<brief_title>20101299 : Study Evaluate Effect AMG 747 Schizophrenia Negative Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Diagnosis Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) schizophrenia Total score PANSS Marder Negative Symptom Factor Scale ( NSFS ) ≥20 Total score PANSS Marder Positive Symptom Factor Scale ( PSFS ) ≤ 30 Receiving stable antipsychotic therapy least 8 week prior screen Receiving stable dose psychotropic agent least 8 week prior screen Subject stable residence live arrangement least 8 week prior screen residence living arrangement anticipated change duration study The subject subject 's legally acceptable representative provide informed consent . Current schizoaffective bipolar disorder , panic disorder , obsessive compulsive disorder , evidence mental retardation history clinical examination know premorbid IQ ≤ 70 Clinically significant suicidal ideation suicide attempt , assaultive behavior mark change mood within 8 week prior screen , currently endorse suicidal ideation clinical exam Substance abuse ( exception nicotine caffeine abuse ) within 8 week prior screen , screen Substance dependence ( exception nicotine caffeine dependence ) within 6 month prior screen , screen Planning initiate smoking cessation therapy otherwise substantially modify nicotine use study Positive urine drug test substance abuse ( exception positive screen prescribe agent benzodiazepine ) . Other criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>schizophrenia negative symptom</keyword>
</DOC>